Huang C, Gu X, Zeng X, Chen B, et al. Cetuximab versus bevacizumab following prior FOLFOXIRI and bevacizumab in postmenopausal women with advanced KRAS and BRAF wild-type colorectal cancer: a retrospective study. BMC Cancer 2021;21:30.
PMID: 33413175